Vir Biotechnology Inc (NASDAQ: VIR) is -20.38% lower on its value in year-to-date trading and has touched a low of $7.12 and a high of $13.09 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The VIR stock was last observed hovering at around $8.64 in the last trading session, with the day’s loss setting it -0.63%.
Currently trading at $8.01, the stock is -6.11% and 0.08% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.48 million and changing -7.29% at the moment leaves the stock -12.94% off its SMA200. VIR registered -17.25% loss for a year compared to 6-month loss of -17.68%. The firm has a 50-day simple moving average (SMA 50) of $8.0034 and a 200-day simple moving average (SMA200) of $9.200625.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 3.76% gain in the last 1 month and extending the period to 3 months gives it a -8.67%, and is -16.56% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.66% over the week and 6.41% over the month.
Vir Biotechnology Inc (VIR) has around 587 employees, a market worth around $1.02B and $78.62M in sales. Profit margin for the company is -678.40%. Distance from 52-week low is 12.50% and -38.81% from its 52-week high. The company has generated returns on investments over the last 12 months (-39.98%).
with sales reaching $8.14M over the same period.The EPS is expected to grow by 16.32% this year, but quarterly earnings will post -20.34% year-over-year. Quarterly sales are estimated to shrink -51.51% in year-over-year returns.
Vir Biotechnology Inc (VIR) Top Institutional Holders
301.0 institutions hold shares in Vir Biotechnology Inc (VIR), with institutional investors hold 84.48% of the company’s shares. The shares outstanding are 134.78M, and float is at 87.38M with Short Float at 6.55%. Institutions hold 74.47% of the Float.
The top institutional shareholder in the company is SB INVESTMENT ADVISERS (UK) LTD with over 16.68 million shares valued at $148.49 million. The investor’s holdings represent 12.3329% of the VIR Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 16.43 million shares valued at $146.26 million to account for 12.1482 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 12.85 million shares representing 9.4982% and valued at over $114.36 million, while STATE STREET CORP holds 3.7662 of the shares totaling 5.09 million with a market value of $45.34 million.
Vir Biotechnology Inc (VIR) Insider Activity
The most recent transaction is an insider sale by de Verneuil Vanina, the company’s EVP and General Counsel. SEC filings show that de Verneuil Vanina sold 4,397 shares of the company’s common stock on Nov 06 ’24 at a price of $10.11 per share for a total of $44454.0. Following the sale, the insider now owns 56973.0 shares.
Still, SEC filings show that on Nov 05 ’24, de Verneuil Vanina (EVP and General Counsel) disposed off 2,347 shares at an average price of $9.47 for $22225.0. The insider now directly holds 61,370 shares of Vir Biotechnology Inc (VIR).
